Skip to main content

Yakult Honsha Co.,Ltd. (YKLTF)

New York Stock Exchange Consumer Defensive Beverages - Non-AlcoholicView data quality →
65.8Fair

ValueMarkers Composite Index

Top 96%#1,986 of 44,707
Undervalued

66% below intrinsic value ($0)

UndervaluedFair ValueOvervalued
Piotroski
5/9
Neutral
Beneish
-2.86
Low Risk
Altman
1.99
Grey Zone
DCF Value
$0
Undervalued
ROIC
4.0%
Low
P/E
17.7
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Yakult Honsha Co.,Ltd. (YKLTF) — VMCI valuation read

Yakult Honsha Co.,Ltd. sits at VMCI 66/100, with the Consumer Defensive sector median at 50. That 16-point spread is the first thing to note on YKLTF: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on YKLTF are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on YKLTF: YKLTF trades at 18.0x earnings, 0% above the Consumer Defensive median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 16.0% sits 6.0pp above the Consumer Defensive median (10.0%). The Risk read: net debt to EBITDA of 3.4x is the binding constraint on the bear case, anchoring the bear scenario on a measurable balance-sheet metric.

YKLTF rose 0.8% over the trailing 7 days, with a -1.2% read on a 30-day basis.

Yakult Honsha Co.,Ltd. manufactures and sells food and beverage products, cosmetics, pharmaceuticals, and others. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, an antineoplastic drug, as well as generic anti-cancer agents, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. In addition, the company offers cosmetics; and operates the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.

CEO: Hiroshi Natsume29,627 employeesJPwww.yakult.co.jp

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in YKLTF’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.